Universitätsklinikum Tulln

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Multiple system atrophy1 trial

Phase

• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial

Lead sponsor

• Abbott Medical Devices1 trial
• Theravance Biopharma1 trial

Running trials

• Active, not recruiting

  Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

  NCT05696717· Phase 3· Theravance Biopharma· Source

Closed trials

• Completed

  Confirm Rx Insertable Cardiac Monitor SMART Registry

  NCT03505801· Abbott Medical Devices· Source